169 related articles for article (PubMed ID: 35811347)
21. A randomized controlled trial of oxygen therapy for patients who do not respond to upper airway surgery for obstructive sleep apnea.
Joosten SA; Tan M; Wong AM; Landry SA; Leong P; Sands SA; Beatty C; Thomson L; Stonehouse J; Turton A; Hamilton GS; Edwards BA
J Clin Sleep Med; 2021 Mar; 17(3):445-452. PubMed ID: 33094725
[TBL] [Abstract][Full Text] [Related]
22. Drug therapy for obstructive sleep apnoea in adults.
Mason M; Welsh EJ; Smith I
Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
[TBL] [Abstract][Full Text] [Related]
23. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
Mason M; Cates CJ; Smith I
Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
[TBL] [Abstract][Full Text] [Related]
24. Drug therapy for obstructive sleep apnoea in adults.
Smith I; Lasserson TJ; Wright J
Cochrane Database Syst Rev; 2006 Apr; (2):CD003002. PubMed ID: 16625567
[TBL] [Abstract][Full Text] [Related]
25. Zolpidem increases sleep efficiency and the respiratory arousal threshold without changing sleep apnoea severity and pharyngeal muscle activity.
Messineo L; Eckert DJ; Lim R; Chiang A; Azarbarzin A; Carter SG; Carberry JC
J Physiol; 2020 Oct; 598(20):4681-4692. PubMed ID: 32864734
[TBL] [Abstract][Full Text] [Related]
26. Changes in pharyngeal collapsibility and genioglossus reflex responses to negative pressure during the respiratory cycle in obstructive sleep apnoea.
Osman AM; Carberry JC; Gandevia SC; Butler JE; Eckert DJ
J Physiol; 2020 Feb; 598(3):567-580. PubMed ID: 31782971
[TBL] [Abstract][Full Text] [Related]
27. Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation.
Taranto-Montemurro L; Sands SA; Edwards BA; Azarbarzin A; Marques M; de Melo C; Eckert DJ; White DP; Wellman A
Eur Respir J; 2016 Nov; 48(5):1340-1350. PubMed ID: 27799387
[TBL] [Abstract][Full Text] [Related]
28. The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.
Schweitzer PK; Taranto-Montemurro L; Ojile JM; Thein SG; Drake CL; Rosenberg R; Corser B; Abaluck B; Sangal RB; Maynard J
Am J Respir Crit Care Med; 2023 Dec; 208(12):1316-1327. PubMed ID: 37812772
[No Abstract] [Full Text] [Related]
29. Stepwise Add-On and Endotype-informed Targeted Combination Therapy to Treat Obstructive Sleep Apnea: A Proof-of-Concept Study.
Aishah A; Tong BKY; Osman AM; Pitcher G; Donegan M; Kwan BCH; Brown E; Altree TJ; Adams R; Mukherjee S; Eckert DJ
Ann Am Thorac Soc; 2023 Sep; 20(9):1316-1325. PubMed ID: 37159953
[No Abstract] [Full Text] [Related]
30. Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial.
Sands SA; Collet J; Gell LK; Calianese N; Hess LB; Vena D; Azarbarzin A; Bertisch SM; Landry S; Thomson L; Joosten SA; Hamilton GS; Edwards BA
Thorax; 2024 Feb; 79(3):259-268. PubMed ID: 38286618
[TBL] [Abstract][Full Text] [Related]
31. Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial.
Berger M; Solelhac G; Marchi NA; Dussez R; Bradley B; Lecciso G; Heiniger G; Bayon V; Van Den Broecke S; Haba-Rubio J; Siclari F; Heinzer R
Sleep; 2023 Jul; 46(7):. PubMed ID: 36861433
[TBL] [Abstract][Full Text] [Related]
32. Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea.
Edwards BA; Sands SA; Eckert DJ; White DP; Butler JP; Owens RL; Malhotra A; Wellman A
J Physiol; 2012 Mar; 590(5):1199-211. PubMed ID: 22219335
[TBL] [Abstract][Full Text] [Related]
33. Response to a combination of oxygen and a hypnotic as treatment for obstructive sleep apnoea is predicted by a patient's therapeutic CPAP requirement.
Landry SA; Joosten SA; Sands SA; White DP; Malhotra A; Wellman A; Hamilton GS; Edwards BA
Respirology; 2017 Aug; 22(6):1219-1224. PubMed ID: 28409851
[TBL] [Abstract][Full Text] [Related]
34. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold.
Eckert DJ; Owens RL; Kehlmann GB; Wellman A; Rahangdale S; Yim-Yeh S; White DP; Malhotra A
Clin Sci (Lond); 2011 Jun; 120(12):505-14. PubMed ID: 21269278
[TBL] [Abstract][Full Text] [Related]
35. Clinical polysomnographic methods for estimating pharyngeal collapsibility in obstructive sleep apnea.
Vena D; Taranto-Montemurro L; Azarbarzin A; Op de Beeck S; Marques M; Vanderveken OM; Edwards BA; Gell L; Calianese N; Hess LB; Radmand R; Hamilton GS; Joosten SA; Verbraecken J; Braem M; White DP; Redline S; Sands SA; Wellman A
Sleep; 2022 Jun; 45(6):. PubMed ID: 35238379
[TBL] [Abstract][Full Text] [Related]
36. Effect of Venlafaxine on Apnea-Hypopnea Index in Patients With Sleep Apnea: A Randomized, Double-Blind Crossover Study.
Schmickl CN; Li Y; Orr JE; Jen R; Sands SA; Edwards BA; DeYoung P; Owens RL; Malhotra A
Chest; 2020 Aug; 158(2):765-775. PubMed ID: 32278781
[TBL] [Abstract][Full Text] [Related]
37. Structure and severity of pharyngeal obstruction determine oral appliance efficacy in sleep apnoea.
Marques M; Genta PR; Azarbarzin A; Taranto-Montemurro L; Messineo L; Hess LB; Demko G; White DP; Sands SA; Wellman A
J Physiol; 2019 Nov; 597(22):5399-5410. PubMed ID: 31503323
[TBL] [Abstract][Full Text] [Related]
38. The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility.
Edwards BA; Sands SA; Owens RL; Eckert DJ; Landry S; White DP; Malhotra A; Wellman A
Sleep; 2016 Nov; 39(11):1973-1983. PubMed ID: 27634790
[TBL] [Abstract][Full Text] [Related]
39. A novel TASK channel antagonist nasal spray reduces sleep apnea severity in physiological responders: a randomized, blinded, trial.
Osman AM; Toson B; Naik GR; Mukherjee S; Delbeck M; Hahn M; Muller T; Weimann G; Eckert DJ
Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H715-H723. PubMed ID: 38214905
[TBL] [Abstract][Full Text] [Related]
40. Combined noradrenergic plus antimuscarinic agents for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials.
Zha S; Yang H; Yue F; Zhang Q; Hu K
Sleep Med Rev; 2022 Aug; 64():101649. PubMed ID: 35709641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
